DNA targeting of rhinal cortex D2 receptor protein reversibly blocks learning of cues that predict reward

Zheng Liu1, Barry J Richmond, Elisabeth A Murray

  • 1Laboratory of Neuropsychology, Clinical Neuroscience Branch, and Behavioral Endocrinology Branch, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA.

Insights

Monkeys use visual cues to learn complex trial schedules. Dopamine D2 receptors in the rhinal cortex are crucial for this learning, with targeted DNA decreasing receptor function temporarily impairing performance.

Area of Science:

  • Neuroscience
  • Cognitive Science
  • Molecular Biology

Background:

  • Monkeys learn to use visual cues for complex operant trial schedules.
  • Bilateral rhinal cortex ablations cause irreversible learning deficits in this task.
  • The role of dopamine D2 receptors in rhinal cortex learning remains unclear.

Purpose of the Study:

  • To investigate the role of dopamine D2 receptors in the primate rhinal cortex for cue-related learning.
  • To explore the potential of recombinant DNA techniques for studying receptor function in vivo.
  • To determine if dopamine D2 receptor manipulation in the rhinal cortex affects learning of trial schedules.

Main Methods:

  • Recombinant DNA technology was used to inject DNA constructs into the rhinal cortex of monkeys.
  • One DNA construct specifically decreased dopamine D2 receptor ligand binding.
  • Another construct targeted N-methyl-D-aspartate receptors, serving as a control.

Main Results:

  • Decreasing dopamine D2 receptor binding temporarily impaired cue-related learning, mimicking ablation effects.
  • Unlike ablations, this deficit was reversible, with recovery observed within 11-19 weeks.
  • Targeting N-methyl-D-aspartate receptors did not interfere with learning, highlighting D2 receptor specificity.

Conclusions:

  • Dopamine D2 receptors in the primate rhinal cortex are essential for learning to associate visual cues with trial schedules.
  • Recombinant DNA techniques offer a specific and potentially reversible method to study molecular mechanisms in cognitive functions.
  • This approach can be generalized to investigate other receptor-ligand interactions in various brain pathways.

Related Concept Videos